- Bruce Bernstein, Branko Pejic and Michael Fink have provided the United States section for the 2019 edition of LICENSING - GETTING THE DEAL THROUGH, available in print and on-line, Law Business Research Ltd. Messrs. Bernstein, Pejic and Fink have provided the United States’ section for each annual edition since 2011. The United States section can be accessed here.
- Michael Fink spoke at the BPIP Conference on April 8, 2019.
- Neil Greenblum led a seminar at the Compagnie Nationale des Conseils en Propriété Industrielle (CNCPI) on April 4, 2019.
- Neil Greenblum and Jeff Handelsman lectured at the Centre for International Intellectual Property Studies, or Centre d'Etudes Internationales de la Propriété Intellectuelle (CEIPI) from April 1-3.
- Jon Miller moderated Intellectual Property for Beginners Panel Discussion at Winter NAMM 2019.
- The 2018 Cumulative Supplement to Post-Grant Patent Practice, Second Edition, a treatise authored by Bruce Stoner and several other former administrative patent judges, was published in December 2018 by Bloomberg Law.
- On September 24, 2018, Bruce Stoner participated as a panelist for “The Supreme AIA Update: A Triple-Header” at the IPO Annual Meeting in Chicago. The panelists addressed the likely impacts of the Supreme Court’s recent Oil States and SAS Institute decisions and discussed the granted Helsinn Healthcare certiorari petition.
- Harry Gwinnell and the Honorable Judge Peter M. Reyes, Jr., Minnesota Court of Appeals, conducted a “Fireside Chat” on careers in Intellectual Property Law at George Washington University Law School.
- Harry Gwinnell presents to Rutgers University and Ohio State University students as a guest lecturer on Intellectual Property.
- Bruce Bernstein moderated a panel at the LESI 2018 Annual Conference on April 30, 2018 in San Diego, California.
- Jeff Handelsman spoke on a panel at the AIPPI Israel Conference on April 30, 2018 in Tel Aviv, Israel.
- Branko Pejic has been elected Secretary of the U.S. Section of FICPI (Fédération Internationale Des Conseils En Propriété Intellectuelle/International Federation of Intellectual Property Attorneys)
- Neil Greenblum and Jeff Handelsman lectured on U.S. patent and trademark law at the Centre d'Etudes Internationales de la Propriété Intellectuelle (CEIPI) in Strasbourg, France on March 19-21.
- Michael Fink presented at the Best Practices in Intellectual Property Conference on March 12-13, 2018 in Tel Aviv, Israel. G&B is a Gold Sponsor of the event.
- Harry Gwinnell presented as part of an AIPLA Leadership and Innovation Panel on January 24, 2018, in La Quinta California.
- Harry Gwinnell presents IP Strategy Webinar to UK Chartered Institute of Patent Attorneys.
- Greenblum & Bernstein hosted their annual U.S. Patent Law Seminar, September 25 through October 6, 2017. The Seminar included daily lectures and interactive discussions on U.S. patent practice, including recent changes to U.S. Patent laws and patent office procedures. There were also sessions devoted to additional topics such as monetization and enforcement of Intellectual Property in the U.S.
- Neil F. Greenblum and Justine Nespoulous co-authored: Droit américain des brevets – Les procédures non judiciaires après délivrance, Encyclopédie JurisClasseur Brevets - Fasc. 4489-20 (2017).
- Harry Gwinnell guest speaker at IPO Women in IP Committee.
- Harry Gwinnell presents at USPTO Global Intellectual Property Academy.
- Bruce Bernstein recognized in Who’s Who Legal: Patents 2017.
- Bill Boshnick lectured before Japan Patent Attorneys Association in Tokyo and Osaka, Japan.
- Harry Gwinnell and Michael Fink presented at the Best Practices in Intellectual Property Conference on March 27-28, 2017 in Tel Aviv, Israel. G&B was a Gold Sponsor of the event.
- Paul Braier spoke at the 6th Annual Pharma IPR 2017 conference in Mumbai March 1, 2017.
- Branko Pejic was on the organizing committee for the FICPI ABC meeting held in Miami, March 12-15, and Mr. Pejic also spoke on an international panel discussing recent intellectual property trends and developments in the Biologics and Pharmaceutical Industries
- More
